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Iron regulatory proteins (Irps) 1 and 2 posttranscrip-
tionally control the expression of transcripts that
contain iron-responsive element (IRE) sequences,
including ferritin, ferroportin, transferrin receptor,
and hypoxia-inducible factor 2a (HIF2a). We report
here that mice with targeted deletion of Irp1 devel-
oped pulmonary hypertension and polycythemia
that was exacerbated by a low-iron diet. Hematocrits
increased to 65% in iron-starved mice, and many
polycythemic mice died of abdominal hemorrhages.
Irp1 deletion enhanced HIF2a protein expression in
kidneys of Irp1/mice, which led to increased eryth-
ropoietin (EPO) expression, polycythemia, and con-
comitant tissue iron deficiency. Increased HIF2a
expression in pulmonary endothelial cells induced
high expression of endothelin-1, likely contributing
to the pulmonary hypertension of Irp1/ mice. Our
results reveal why anemia is an early physiological
consequence of iron deficiency, highlight the physio-
logical significance of Irp1 in regulating erythro-
poiesis and iron distribution, and provide important
insights into the molecular pathogenesis of pulmo-
nary hypertension.
INTRODUCTION
Iron is an essential element to virtually all organisms, as it is
a crucial component of heme and iron sulfur proteins and is
indispensable for DNA replication, oxygen transport, and ATP
production. Iron deficiency usually causes anemia, whereas
iron overload can generate reactive oxygen species and damage
lipids, DNA, and proteins in diseases such as hemochromatosis,Cell Mcancer, and cardiovascular and neurodegenerative diseases
(reviewed in Rouault, 2006; Hentze et al., 2010). Therefore iron
homeostasis must be precisely regulated.
Cellular iron homeostasis is mainly controlled by the iron-
regulatory protein (Irp)/iron-responsive element (IRE) machinery
inmammalian cells. Iron-regulatory proteins regulate the expres-
sion of target proteins posttranscriptionally by binding to IREs
in transcripts that mostly encode iron metabolism proteins,
including the iron storage proteins, H- and L-ferritin, iron uptake
proteins, transferrin receptor 1 (Tfrc), divalent metal transporter 1
(Dmt1), the iron export protein, ferroportin, and several other
transcripts. By inhibiting the translation of proteins involved in
iron export, storage, and utilization, and stabilizing the tran-
scripts of proteins involved in iron uptake, the Irp/IRE machinery
regulates cellular iron homeostasis in response to intracellular
iron status (Rouault, 2006; Hentze et al., 2010). Though the two
Irps, Irp1 and Irp2, share high sequence similarity, they are regu-
lated by different mechanisms. Irp1 is a bifunctional protein that
binds to IREs in iron-deficient conditions when it is an apopro-
tein, but it converts to cytosolic aconitase in iron-replete condi-
tions upon acquisition of a [4Fe-4S] cluster in the active site cleft
that separates domains 1–3 from domain 4 (Dupuy et al., 2006;
Walden et al., 2006). Irp2 is active as an IRE-binding protein in
iron-deficient cells, because it is otherwise rapidly degraded in
iron-replete conditions as a result of FBXL5-mediated ubiquiti-
nation and subsequent proteasomal degradation (Salahudeen
et al., 2009; Vashisht et al., 2009). Previously, we and others re-
ported that mice with a targeted deletion of Irp2 (Irp2/) devel-
oped adult-onset neurodegeneration and anemia (LaVaute et al.,
2001; Cooperman et al., 2005; Galy et al., 2005), as the tissues
and cells that were adversely affectedwere largely dependent on
Irp2 for regulation, and residual Irp1 did not appear to compen-
sate for the loss of Irp2 in affected cells, whereas Irp2 could
compensate for loss of Irp1 in many cells (Meyron-Holtz et al.,
2004a). Complete loss of Irp1 and Irp2 causes early embryonic
lethality, implying that Irp1 and Irp2 have redundant functions
(Smith et al., 2006). However, mice with a targeted deletion ofetabolism 17, 271–281, February 5, 2013 ª2013 Elsevier Inc. 271
Cell Metabolism
Role of Irp1 in Erythropoiesis and Pulmonary HypertensionIrp1 (Irp1/ mice) did not display an easily recognizable pheno-
type when maintained on a normal iron diet, which raised ques-
tions about the physiological role of Irp1 in iron homeostasis.
One of the more recently identified targets of the Irp/IRE
system is HIF2a (also known as Endothelial PAS Domain protein
1, EPAS1), a transcription factor that belongs to the hypoxia-
inducible factor (HIF) a protein family. In response to hypoxia,
anemia, or iron deficiency, HIF2a heterodimerizes with HIF1b
and translocates into the nucleus to regulate the expression of
genes involved in the adaptive response to hypoxia, including
erythropoietin (EPO) (Semenza, 2012). Under normoxia, prolyl
hydroxylase domain protein 2 (PHD2) site-specifically hydroxyl-
ates HIF2a, thereby targeting the latter for ubiquitination by
the von Hippel-Lindau (vHL) E3 ligase complex and proteasomal
degradation (Kaelin and Ratcliffe, 2008). Evidence is growing
that HIF2a is the master regulator for erythropoiesis in the adap-
tive response to hypoxia, and mutations of the proteins in this
pathway, including HIF2a, PHD2, and vHL, are implicated in dys-
regulation of erythropoiesis (Majmundar et al., 2010). Recently it
was found that HIF2a contains an IRE in its 50UTR, and Irps could
bind and inhibit the translation of HIF2amRNA in vitro, suggest-
ing that iron homeostasis and erythropoiesis could be potentially
linked by HIF2a (Sanchez et al., 2007; Zimmer et al., 2008).
However, the relevance of the IRE in the 50UTR of the HIF2a tran-
script in mammalian physiology has not been established.
In this study, to investigate the physiological significance of
Irp1 in iron metabolism, we challenged Irp1/ mice with iron
deficiency, and we found that deletion of Irp1 increased HIF2a
expression, which in turn stimulated EPO and endothelin-1
expression, leading to polycythemia, pulmonary hypertension,
and early sudden death from hemorrhage.
RESULTS
Irp1–/– Mice on Low-Iron Diet Die Early of Abdominal
Hemorrhages
To challenge the mice with iron deficiency, we maintained the
wild-type (WT) and Irp1/ mice (15–18 per group) on a low-
iron diet for up to 24 months. We found that the Irp1/ mice
on the low-iron diet were prone to sudden death when they
were as young as 3 months of age (Figure 1A, see Figure S1A
online), and 50%of thesemice had died by the age of 10months.
The autopsies revealed gross abdominal hemorrhages as the
presumed cause of death for almost all of the Irp1/ mice that
diedwhile on the low-iron diet (Figure 1B). To further characterize
the causes of sudden death, we evaluated the iron status and
tissue pathology of Irp1/ mice. Compared with their WT coun-
terparts, Irp1/ mice had low serum iron levels (Figure 1C),
lower transferrin saturations (Figure 1D), and low stainable
nonheme iron in tissues such as spleen and bone marrow (Fig-
ure 1E, Figure S1B), suggestive of systemic iron deficiency.
However, low dietary iron uptake was not the cause of iron defi-
ciency in Irp1/ mice, as the intestinal iron uptake machinery
was functional and responsive (Figures S1C–S1E).
Irp1–/– Mice Develop Polycythemia with Extramedullary
Erythropoiesis
To determine whether abnormal erythropoiesis was responsible
for the abdominal hemorrhages that caused early death, we272 Cell Metabolism 17, 271–281, February 5, 2013 ª2013 Elsevier Inevaluated complete blood counts of Irp1/ mice. Strikingly,
hematocrits of Irp1/ animals were elevated on the normal
diet and increased further, to as high as 65% in Irp1/ mice,
on the low-iron diet (Figure 2A). The hematocrits were also
increased in young Irp1/ animals (Figure S2A). RBC and hemo-
globin levels were higher in Irp1/ mice, whereas MCV and
MCH levels were lower, consistent with systemic iron deficiency
in Irp1/ mice (Table S1). Extramedullary erythropoiesis in-
creased in Irp1/ mice, especially in the mice maintained on
a low-iron diet, as evidenced by expansion of splenic red pulp
(Figure 2B), gross splenomegaly (Figure 2C, Figure S2B), and
increased percentages of Ter119-positive immature erythroid
cells as assessed by fluorescence-activated cell sorting
(FACS) analysis (Figure 2D). We did not see evidence for an
expansion of hematopoiesis in bone marrow cross-sections of
Irp1/ mice (Figure S2D). Though the spleen showed less ferric
nonheme iron in histologic stains (Figure 1E), total splenic iron
measured by ICP-MS was higher in Irp1/ mice on the normal
diet (Figure S2C), suggesting that splenic iron was mainly incor-
porated into heme. Thus, increased diversion of iron for
expanded erythropoiesis likely caused systemic iron deficiency,
as evidenced by low serum transferrin saturations and low tissue
iron stains (Figures 1C–1E).
To determine the cause of polycythemia in Irp1/ mice, we
analyzed levels of EPO and observed that both serum EPO (Fig-
ure 2E) and EPO mRNA levels in kidney (Figure S2E) were
significantly increased in Irp1/ mice, especially in mice on
the low-iron diet. Because EPO is a known transcriptional target
of HIF2a (Semenza, 2012), we assessed the HIF2a protein levels
in renal lysates of WT and Irp1/ animals (Figure 2F) and
observed that HIF2a protein levels were increased in the EPO-
producing interstitial renal fibroblasts (Pan et al., 2011) of
Irp1/ mice, particularly in the mice on low-iron diet (Figure 2G,
Figure S2F). Since the HIF2a transcript is a known Irp1 target
(Sanchez et al., 2007; Zimmer et al., 2008), and HIF2a mRNA
levels remained unchanged (Figure S2G), we hypothesized that
loss of Irp1 allowed unrepressed translation of HIF2a in intersti-
tial fibroblasts, which activated expression of HIF2a target genes
including EPO, and thereby increased red blood cell (RBC)
production, causing polycythemia (Figure 2A) and redistribution
of iron from tissues to developing erythroid cells (Figure 1E).
Irp1–/– Mice Develop Pulmonary Hypertension
Since high hematocrits stress cardiovascular function, we eval-
uated the potential contribution of cardiac disease to the pheno-
type of sudden death with cardiac ultrasound. Abnormal motion
of the interventricular wall during systole in Irp1/ animals sug-
gested that there was pulmonary hypertension (Figure 3A, Movie
S1). There was also hypertrophy of the cardiac walls (Figures 3B
and 3C). Systolic ejection fractions did not change in Irp1/
mice, indicating normal cardiac contractility (Figure S3A).
Catheterization of the right ventricle revealed that pulmonary
pressures were significantly elevated in Irp1/ animals at both
3 and 12 months of age (Figure 3D) but did not increase further
in Irp1/ mice on low-iron diet, in contrast to the polycythemic
response. At autopsy, areas of fibrosis and cardiomyocyte
degeneration were present throughout the heart (Figure 3E, Fig-
ure S3E). However, discernible changes in the pulmonary vascu-
lature (Figures S3B and S3C) and thromboses were rarelyc.
Figure 1. Reduced Life Expectancy of Irp1–/– Mice Is Exacerbated by Iron Deficiency
(A) Survival curves for mice with indicated genotypes and diets.
(B) Image of a 3-month-old low-iron-diet Irp1/ mouse that died from abdominal hemorrhage in the perinephric area (white arrows).
(C andD) (C) Serum iron and (D) transferrin saturation in 1-year-old normal diet (N) or low-iron diet (L) mice (n = 5 per group) showing iron deficiency in low-iron-diet
Irp1/ mice.
(E) Representative Prussian blue staining of spleen and bone marrow of WT and Irp1/ mice maintained on normal (N) or low-iron (L) diets showing low ferric
nonheme iron stores in Irp1/ mice (n = 4–5 per group). Data are represented as mean ± SD. See also Figure S1.
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Figure 2. Irp1–/– Mice Have Polycythemia and Enhanced Extramedullary Hematopoiesis, High Serum EPO, and Elevated Renal HIF2a
Expression
(A) Hematocrits of 1-year-old animals as determined by capillary tube centrifugation were significantly higher in Irp1/ mice on both normal and low-iron diets.
(B) Representative H&E staining of spleens from WT and Irp1/ mice on normal (N) or low-iron (L) diets showed increased red pulp and diminished white pulp
(WP) in Irp1/ mice.
(C) Spleens of 1-year-old mice of iron-starved Irp1/mice were significantly larger than in WT mice, demonstrating splenomegaly in Irp1/ animals maintained
on the low-iron diet.
(legend continued on next page)
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Role of Irp1 in Erythropoiesis and Pulmonary Hypertensionobserved (data not shown). Notably, the low-iron diet did not
induce pulmonary hypertension or cardiac hypertrophy of the
WT mice. Moreover, the resistance and tissue damping of
Irp1/ lung measured by FlexiVent were significantly lower (Fig-
ure S3D), and the oxygen and carbon dioxide tensions in arterial
blood of Irp1/ were normal (results not shown), suggesting
that the pulmonary functions of Irp1/ mice are within the
normal range.
Pulmonary Hypertension in Irp1–/–Mice Was Associated
with High Expression of HIF2a in Pulmonary Endothelial
Cells and Transcriptional Activation of Endothelin-1
As abnormally high HIF2a expression has been implicated in the
pathogenesis of polycythemia (Formenti et al., 2010) and pulmo-
nary hypertension (Hickey et al., 2010), we evaluated the ex-
pression of HIF2a in the pulmonary vascular system. Although
immunohistochemistry and immunoblots of total lung lysates
did not reveal reproducible increases in HIF2a protein levels
(data not shown), we found increased HIF2a expression in
specific cells of other tissues such as kidney (Figure 2G) and
spleen (Figure S4A). Moreover, in primary pulmonary endothelial
cells isolated from WT and Irp1/ animals, and cultured at low
oxygen tensions, HIF2a protein levels increased significantly in
Irp1/ cells (Figure 4A) cultured under both normal and low-
iron conditions, whereas mRNA levels did not increase (Fig-
ure S4B). Endothelin-1, a HIF target and potent vasoconstrictor,
has been implicated in the pathogenesis of pulmonary hyperten-
sion, tissue hypertrophy, and fibrosis (Shao et al., 2011). We
found that endothelin-1 expression significantly increased in
Irp1/ pulmonary endothelial cell lysates and cell media (Fig-
ure 4B, Figure S4C) but did not increase upon treatment with
the iron chelator, desferrioxamine (Dfo). Endothelin-1 also
increased in serum (Figure S4D) and lung tissue of Irp1/
mice at 3 months of age, as determined by ELISA (Figure 4C)
and mRNA quantification (Figure 4D), and also at 12 months of
age (Figure S4E). As observed in primary pulmonary endothelial
cells (Figure 4B), endothelin-1 expression did not increase in the
lung tissue lysates of low-iron-diet Irp1/ animals (Figure 4E),
possibly explaining why pulmonary hypertension was not exac-
erbated by the low-iron diet. Expression of other known HIF
targets also increased (Figures S4F–S4I), including Aldoa,
a key glycolytic enzyme; Cxcl12, a chemokine involved in in-
flammation; Bnip3, a proapoptotic factor; and Retnla, also
known as Himf (hypoxia-induced mitogenic factor), a member
of the resistin family proposed to drive vascular remodeling
and pulmonary hypertension in amousemodel of hypoxia-driven
pulmonary hypertension (Hickey et al., 2010). In contrast, HIF1a
protein levels did not change in Irp1/ pulmonary endothelial
cells (Figure 4A), indicating that the major prolyl hydroxylase-
dependent HIF degradation pathway was not altered in Irp1/
endothelial cells (Kaelin and Ratcliffe, 2008). Therefore, changes
in HIF2a expression occurred in the absence of transcriptional(D) Representative flow cytometric analyses of splenic cell populations from W
increase of Ter119+ erythroid precursors in Irp1/ mice.
(E) Serum EPO levels measured by ELISA were increased in Irp1/ mice, partic
(F) Immunoblot analysis of nuclear fractions from kidney lysates (n = 5 per g
expression in Irp1/mice that increased on the low-iron diets. Arrows point to int
expression. Data are represented as mean ± SD. See also Figure S2.
Cell Mchanges or changes in degradation, implying that the loss of
translational repressor activity caused by loss of Irp1 was the
major factor that drove increased HIF2a expression.
Differences in Tissue-Specific Expression Levels of Irp1
and Irp2 Explain Why Irp1–/–Mice Develop Polycythemia
and Pulmonary Hypertension, whereas Irp2–/– Mice
Develop Neurodegeneration
The two major phenotypic features of Irp1/ animals reported
here, namely polycythemia exacerbated by iron deficiency and
associated with abdominal hemorrhage, and pulmonary hyper-
tension associated with cardiac fibrosis, occurred respectively
in two tissues, kidney and lung, that contained cells in which
HIF2a expression increased markedly as a result of loss of Irp1
translational repressor activity. Notably, these phenotypes
were not observed in Irp2/ animals (data not shown). To
explore why Irp2/ mice lacked these phenotypes, we tested
whether either Irp1 or Irp2 contributed to regulation of HIF2a
expression in Irp2/ or Irp1/ mouse embryonic fibroblast
(MEF) cells (Figure 5A), and we concluded from our results that
both Irp1 and Irp2 can contribute to regulation of HIF2a expres-
sion. Then we compared relative contributions of Irp1 and Irp2 to
total IRE-binding activity in several different tissues and cell
lines. Notably, there was very little contribution from Irp2 in
kidney or lung tissue (Figure 5B), whereas there was consider-
able contribution from Irp2 in brain, as previously reported
(Meyron-Holtz et al., 2004a; Meyron-Holtz et al., 2004b). In
Irp1/ pulmonary endothelial cells, there was almost no detect-
able IRE binding activity (Figure 5C), even when cells were iron
deprived, whereas Irp2 binding activity was readily detected in
Irp1/ embryonic fibroblasts (MEFs). These findings indicated
that pulmonary endothelial cells depend almost exclusively on
Irp1 to regulate the translation or stability of IRE-containing
transcripts.
DISCUSSION
The polycythemia and systemic iron deficiency that developed in
Irp1/ mice reveal that Irp1 plays a pivotal role in balancing
erythropoiesis and systemic iron homeostasis. As the master
regulator of EPO expression, HIF2a was previously known
to be regulated by hypoxia, anemia, and iron status through
PHD2/vHL-mediated degradation (Gale et al., 2008; Smith
et al., 2008; Bond et al., 2011). Here, we established that Irp1-
mediated translational control plays a previously unrecognized
critical role in regulation of HIF2a expression, and loss of Irp1
activity has serious physiological consequences.
Under hypoxic, anemic, and iron-deficient conditions, HIF2a
protein stabilization induces EPO expression, which increases
production of RBCs in a process that consumes large amounts
of iron. When erythropoiesis consumes enough iron to cause
nonerythroid tissue iron deficiency, synthesis of the iron sulfurT and Irp1/ mice separated with antibodies to CD71 and Ter119 showed
ularly in those on the low iron diet (n = 5–7 per group).
roup) and (G) renal immunohistochemistry showed increased HIF2a protein
erstitial fibroblasts in which intense dark purple stain indicates increased HIF2a
etabolism 17, 271–281, February 5, 2013 ª2013 Elsevier Inc. 275
Figure 3. Irp1–/–Mice Developed Pulmonary
Hypertension and Cardiac Fibrosis
(A) Representative cardiac ultrasound images
showed abnormal motion of the interventricular
septum (IVS) (arrows) during the cardiac cycle.
The IVS flattened and was pushed inward into the
left ventricle (LV) chamber at the end of systole,
giving the LV a D-shaped appearance in the
low-iron-diet Irp1/ mice, suggesting that right
ventricular (RV) pressure was high, whereas
the IVS maintained a normal concave shape
throughout systole in the WT mice on low-iron
diets (n = 5 per group).
(B) In representative parasternal long axis views of
the left ventricle, the IVS and posterior walls (PW)
of the left ventricle were hypertrophied in the iron-
starved Irp1/ mice compared with the iron-
starved wild-type mice (n = 5 per group).
(C) Representative parasternal short axis M mode
of the left ventricle demonstrated significant
hypertrophy of the anterior (AW) and posterior
walls (PW) in Irp1/ mice on low-iron diets (n = 5
per group).
(D) Right ventricular (RV) pressure measured by
catheterization of lightly anesthetized 3-month
and 1-year-old WT and Irp1/ mice showed
significantly elevated pressures in Irp1/ mice.
Data are represented as mean ± SD (n = 3 per
group).
(E) Representative H&E staining of hearts fromWT
and Irp1/ mice on normal and low-iron diet
showed extensive fibrosis in Irp1/ mice, though
cardiac function was not compromised (see text).
See also Figure S3, Movie S1.
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tein form that binds to IREs. Apo-Irp1 represses HIF2a
translation, decreases EPO production, and thereby diminishes
RBC production (Figure 6). Through this Irp1/HIF2a-dependent
feedback mechanism, the body balances erythropoietic
activity and systemic iron availability to ensure that high RBC
production in iron-deficient animals does not deplete iron stores
in tissues such as the heart, brain, and kidneys and compromise
crucial cellular functions such as mitochondrial respiration. In
Irp1/ mice, derepression of HIF2a translation increases
HIF2a protein levels, which stimulates EPO expression, which
in turn drives red cell production and concomitant systemic
iron deficiency. Moreover, iron deficiency can further stabilize
HIF2a protein levels by diminishing activity of the iron-dependent
prolyl hydroxylases involved in its degradation and can thereby276 Cell Metabolism 17, 271–281, February 5, 2013 ª2013 Elsevier Inc.exacerbate the polycythemia further
(Percy et al., 2006; Kaelin and Ratcliffe,
2008). An increase in the total red cell
volume can increase the blood viscosity
and resistance in vascular tissues, and
can thereby endanger the cardiovascular
system. As shown in the model in Fig-
ure 6, we propose that the extremely
high hematocrits of Irp1/ mice on a
low-iron diet contribute to sudden death
from abdominal hemorrhages, perhapsbecause the high viscosity leads to localized blood pressure
increases. Thus, Irp1/mice represent a unique model in which
iron deficiency exacerbates a mild polycythemia rather than
causing anemia, and in which iron supplementation partially
reverses the polycythemia. Irp1/ mice reveal that the
anemia of iron deficiency normally results from a restriction of
EPO production mediated by renal Irp1, which represses
HIF2a translation and EPO expression when the kidney is iron
deficient.
Irp1/mice develop pulmonary hypertension, and pulmonary
endothelial cells represent another tissue in which Irp1 appears
to play a dominant role. Since the pulmonary endothelial cells
represent a small fraction of the total population of cells in the
lung tissue and they form a thin cell layer covering the vascular
lumen, we did not consistently detect increased HIF2a
Figure 4. Pulmonary Hypertension in Irp1–/– Mice Was Associated with High Expression of HIF2a in Pulmonary Endothelial Cells and
Transcriptional Activation of Multiple Targets
(A) HIF2a protein expression increased in the nuclear fractions of Irp1/ pulmonary endothelial cells relative to WT pulmonary endothelial cells isolated from
mice, cultured at 1% oxygen, and treated (for 15 hr) with or without the iron chelator, desferrioxamine (Dfo,100 mM), whereas HIF1a protein levels remained
unchanged.
(B) Endothelin-1 levels (measured by ELISA) in the lysates of pulmonary endothelial cells isolated fromWT and Irp1/mice and cultured at 1% oxygen (n = 6 per
group).
(C) Endothelin-1 levels in lung lysates of 3-month-old normal diet mice measured by ELISA (n = 5–6 per group).
(D) Endothelin-1 mRNA levels in lungs of 3-month-old normal-diet mice.
(E) Endothelin-1 levels in lung lysates of 1-year-old normal and low-iron-diet mice measured by ELISA (n = 5 per group). Data are represented as mean ± SD.
See also Figure S4.
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we cultured primary pulmonary endothelial cells and found that
HIF2a was significantly increased in primary pulmonary endo-
thelial cells from Irp1/ mice. Increased HIF2a expression
was also confirmed by the expression of some well-known
HIFa targets including the potent vasoconstrictor, endothelin-
1. Endothelin-1 expression is significantly increased in Irp1/
mice and likely plays a major role in the pathogenesis of pulmo-
nary hypertension. Endothelin-1 is known to bind to endothelin-1
receptor type A (ETAR) on smooth muscle cells in the vascular
wall and to induce the contraction of blood vessels (Shao
et al., 2011), leading to increased pulmonary hypertension, asCell Mwe observed. Endothelin-1 also binds to ETAR on cardiomyo-
cytes and fibroblasts and induces their proliferation, leading to
cardiac hypertrophy and fibrosis (Thorin and Clozel, 2010). The
pulmonary hypertension may also contribute to the cardiac
hypertrophy by increasing the workload of the heart as it works
against high resistance in the pulmonary vasculature. The spon-
taneous pulmonary hypertension of Irp1/ mice warrants
further investigation.
An important role for HIF2a in development of polycythemia
and pulmonary hypertension was recently reported in a mouse
model of Chuvash polycythemia (Hickey et al., 2007, 2010). In
Chuvash polycythemia patients, the vHLR200W mutation leadsetabolism 17, 271–281, February 5, 2013 ª2013 Elsevier Inc. 277
Figure 5. Irp1 Is the Major Contributor of IRE-Binding Activity in Kidney and Lung Tissues and in Pulmonary Endothelial Cells
(A) HIF2a western with nuclear fractions of Irp2/, WT, and Irp1/ MEF cells showed that HIF2a expression increased equally upon loss of either Irp1 or Irp2.
Data (n = 5 per group) are represented as mean ± SD.
(B) IRE-binding activity assays of kidney, lung, and forebrain lysates of normal-diet (N) and low-iron-diet (L) WT and Irp1/ mice showed that most of the
IRE-binding activity in kidney and lung tissues was contributed by Irp1, whereas Irp1 was not the major contributor of IRE-binding activity in brain.
(C) IRE binding activity and TfR1 western blots of WT and Irp1/mouse pulmonary endothelial cell lysates and MEF cell lysates in the absence and presence of
100 mM Dfo showed that there was very little contribution from Irp2 to the total IRE-binding activity in pulmonary endothelial cells both at normal and low-iron
conditions (left lanes), whereas Irp2 was readily detectable in MEFs (right lanes).
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production and polycythemia, and also promotes increased en-
dothelin-1 expression and pulmonary hypertension in the lungs
(Sable et al., 2012). In a Chuvashmousemodel carrying the iden-
tical mutation as human patients, mice were protected from
developing pulmonary hypertension by heterozygous deletion
of HIF2a, whereas HIF1a deletion did not prevent pulmonary
hypertension and vascular remodeling, supporting the idea
that HIF2a was pivotal in the pathophysiology of polycythemia
and pulmonary hypertension in the mouse model, and by infer-
ence, in the Chuvash patients. As in Irp1/ mice, Chuvash
patients also show decreased serum iron levels and transferrin
saturation, supporting the notion that iron redistributes into
RBC production. The HIF2a heterozygous mice were also previ-
ously shown to have resistance to pulmonary hypertension
caused by chronic hypoxia, supporting the essential role of
HIF2a in this process (Brusselmans et al., 2003). Moreover, the
HIF2a locus was recently implicated as being important in
successful adaptation to chronic hypoxia at high altitude (Big-
ham et al., 2010; Yi et al., 2010). Irp1/mice confirm the central
role of HIF2a in regulating erythropoiesis and pulmonary hyper-
tension, emphasize the importance of Irp1 in controlling
HIF2a expression, and also suggest a potential treatment for
HIF2a-related diseases including Chuvash polycythemia. Phar-
maceutical activation of the IRE binding activity of Irp1 by chem-
icals such as Tempol (Ghosh et al., 2008) or nitric oxide could
potentially repress HIF2a translation and alleviate the polycy-278 Cell Metabolism 17, 271–281, February 5, 2013 ª2013 Elsevier Inthemia and pulmonary hypertension in patients with problems
in the Irp/HIF2a axis.
In conclusion, our results in Irp1/ mice show that Irp1 plays
an important function in regulating erythropoiesis and maintain-
ing balance with systemic iron status, and the regulation of Irp1
on HIF2a translation represents an important aspect of fine-
tuning of HIF2a expression in physiology. Since human genomes
were recently shown to contain at least 20 loss-of-functionmuta-
tions per genome (MacArthur et al., 2012), and Irp1/ mice
survive to adulthood, we suggest that loss-of-function mutations
of Irp1 may underlie previously unexplained pulmonary hyper-
tension and/or polycythemia in some patients.
EXPERIMENTAL PROCEDURES
Mice
Irp1/ animals were generated by targeting Aco1 (Irp1), propagated by
breeding, and genotyped by Southern blotting using gene-specific probes
as previously described (Meyron-Holtz et al., 2004a). WT and Irp1/ mice
used in this study have a mixed genetic background consisting of 129S4/
SvJae and C57Bl/6. The mice were weaned 3–4 weeks after their birth. Imme-
diately after weaning, mice were maintained on a diet either containing 3.7 ±
0.9 (measured by ICP-MS) mg iron/kg chow (low-iron diet) from Harlan Teklad
or normal diet containing 143 ± 18 mg iron/kg (measured by ICP-MS) chow
(normal diet). Experiments with blood and tissues were performed with
1-year-old mice unless otherwise noted. Whenever possible, siblings were
used in matched study sets to minimize phenotypic variation due to genetic
background. Mice of different genotypes and diets were age and gender
matched for statistical comparisons. All the mouse experiments were donec.
Figure 6. Model for the Molecular Pathogenesis of Polycythemia and Pulmonary Hypertension in Irp1–/– Mice
In renal interstitial fibroblasts and pulmonary endothelial cells, where Irp1 is the predominant IRE-binding protein, Irp1 deficiency results in increased HIF2a
expression through derepression of HIF2a translation. In renal interstitial fibroblasts, HIF2a induces high expression of EPO, which promotes increased RBC
production and consumption of high amounts of iron, thereby causing iron deficiency in nonerythroid tissues. Importantly, the tissue iron deficiency can stabilize
HIF2a protein further and exacerbate the polycythemia. The systemic iron deficiency and high hematocrits probably stress the cardiovascular system and lead to
sudden death from hemorrhages. In pulmonary endothelial cells, elevated expression of HIF2a leads to increased endothelin-1 (ET-1) expression. By binding to
ETAR, ET-1 induces the proliferation and contraction of vascular smoothmuscle cells, resulting in pulmonary hypertension. ET-1 also induces cardiac fibrosis and
hypertrophy when it binds to ETAR. HIF2a also drives increased expression of other HIFa targets, including Aldoa, Cxcl12, Bnip3, and Retnla, and their potential
contributions to pulmonary hypertension remain to be investigated in Irp1/ mice.
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and met NIH guidelines for the humane care of animals.
Hematocrit Measurements
Approximately 100 ml of blood was harvested in to a heparin-coated tube (BD
microtainer tubes with lithium heparin) from each mouse by mandibular
method. Hematocrit tubes were filled with blood to three-quarters full by
capillary action, sealed, and centrifuged for 5 min in a microhematocrit cen-
trifuge (LW Scientific). The hematocrit was measured with the help of a hemat-
ocrit reader.
CBC Measurement
Blood was drawn from mice by mandibular method or by cardiac puncture in
deeply anesthetized mice prior to euthanizing. CBCs were performed on a
Hemavet 1500 (Drew Scientific, Dallas, Texas) analyzer.
Intracardial Pressure Measurements
Intraventricular pressures were measured invasively by using a microtip
pressure transducer catheter connected to an electrostatic chart recorder
(Millar Instruments, Houston). The mice were anesthetized with 1%–3% iso-
flurane, and the right external jugular veins were cannulated. For each mouse,
the catheter was advanced to the right ventricle. Correct placement was veri-
fied according to RV pressure curve, and the pressure and volume tracings
were recorded. Body temperature of the mice was maintained between
37C and 38C, and the data were recorded using LabChart software (AD
Instruments, Colorado Springs). This was a nonsurvival procedure. Animals
were euthanized, while under anesthesia, by cervical dislocation verified by
thoracotomy, or by exsanguination under anesthesia verified by thoracotomy.
Echocardiography
Transthoracic echocardiography was performed with 1-year-old mice with
a high-frequency ultrasound system (VisualSonics, Vevo 2100). All images
were acquired using a MS-400 transducer (VisualSonics) with a center oper-
ating frequency of 30 MHz, and broadband frequency of 18–38 MHz. The axial
resolution of this transducer is 50 mm, and the footprint is 20 mm 3 5 mm. 2D
imageswere obtained formultiple views of the heart. Mmode images of the leftCell Mventricle were collected from the parasternal short axis view at the level of the
midpapillary muscles and obtained by rotating the probe 90 clockwise from
the parasternal long axis view. From the M mode images the LV systolic and
diastolic posterior and anterior wall thicknesses, as well as end systolic and
end diastolic internal LV chamber dimensions (LVIDs, LVIDd), were measured
using the leading edgemethod. The LV functional value of ejection fraction (EF)
was calculated from chamber dimension measurements through system soft-
ware as follows: %EF = 100 ((LV vol;d  LV vol;s)/LV Vol;d) where LV vol;d =
((7.0/(2.4 + LVID;d)) 3 LVID;d3 and LV Vol;s = ((7.0/(2.4 3 LVID;s)) 3 LVID;s3.
Flexivent Procedure for Measurement of Pulmonary Function
To measure lung mechanics, mice were anesthetized, and a cannula was
inserted into the trachea. The mice were then attached to the Scireq FlexiVent
system and were mechanically ventilated. The maintenance of tidal volume
and respiration rate were controlled (150–200 bpm, 7–9 ml/kg, PEEP 3 cm
H20). A few brief sighswere given to themouse to determine lung volume infor-
mation but did not exceed 25 cm H20. After that, the mice were euthanized
while under anesthesia.
Pulmonary Vessel Thickness Assessment
Quantification of the pulmonary vascular media and intima thickness was per-
formed as previously described (Graham et al., 2010).
Immunohistochemistry
Staining for HIF2a was performed following previously published (Jeong and
David, 2006) protocol using rabbit anti-HIF2a antibody (IHC World). Sections
were analyzed using a bright-field microscope (Nikon Eclipse E600).
Fluorescence-Activated Cell Sorting
Freshly isolated spleens were gently poked in cold PBSwith forceps to release
the cells, and the cell suspensions were filtered with a cell strainer to generate
single-cell suspensions. The cells were washed in PBS and resuspended in
PBA buffer (1% bovine serum albumin, 0.1% sodium azide in PBS [pH 7.4]).
Cells (1 3 106) were incubated with FITC-labeled rat anti-mouse CD71 and
PE-CY7 labeled rat anti-mouse TER119 antibodies (BD PharMingen) in PBA
buffer at 4C for 30 min and then were analyzed by FACS on BD FACS Calibur.etabolism 17, 271–281, February 5, 2013 ª2013 Elsevier Inc. 279
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EPO and endothelin-1 were measured by ELISA kit (R&D Systems) according
to the manufacturer’s protocol. The lung lysates were prepared in RIPA buffer
(50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% Na.deoxycholate, 1% Triton
X-100) and diluted 100 times before being measured by ELISA.
Measurement of Total Serum Iron and Transferrin Saturation
Serum iron and unsaturated iron-binding capacity (UIBC) were measured in
nonhemolyzed mouse serum using a Pointe Scientific (Lincoln Park, MI)
Iron/TIBC Reagent Set following the manufacturer’s instructions. Transferrin
saturation was calculated from measured serum iron and UIBC.
Measurement of Iron Concentration in Spleen
Animals were deeply anesthetized, and blood was removed by extensively
perfusing PBS through the hearts. Spleens were harvested and immediately
snap frozen in liquid nitrogen. Total iron concentrations were measured by
inductively coupled plasma mass spectroscopy (ICP-MS) as described (Kim
et al., 2009).
Cell Culture
For pulmonary endothelial cells, endothelial cells from lungs of WT and
Irp1/ mice were isolated following the method of Sobczak et al. (Sobczak
et al., 2010). Lungs from three 8-day-old WT and Irp1/ pups were used for
isolation of pulmonary endothelial cells. The cells were grown at 1% oxygen
and harvested for experiments when they became about 80% confluent.
MEFs of 13-day-old embryos were isolated and cultured from WT, Irp1/,
and Irp2/ mice as previously described (Meyron-Holtz et al., 2004a,
2004b).
RNA Mobility-Shift Assays
Gel retardation assays were performed as previously described (Meyron-Holtz
et al., 2004a) with lysate containing 10 mg of total protein.
Western Blotting and Antibodies
Protein analysis was carried out as previously described (LaVaute et al.,
2001). HIF1a and HIF2a westerns were performed with nuclear fractions
separated following the protocol of ‘‘Active Motif’’ (http://www.activemotif.
com/) from tissues and cells. HIF2a antibody (affinity-purified goat anti-
human) was from R&D Systems, and a final concentration of 1.0 mg/ml was
used as described in R&D protocol. Purified mouse anti-human HIF1a
antibody from BD Biosciences was used at 1:1,000 dilution. A mouse mono-
clonal Tfr1 antibody from Zymed was used at 1:2,000 dilution. Western blots
were treated with secondary peroxidase-conjugated bovine anti-goat IgG
antibody from Santa Cruz Biotechnology, Inc. or sheep anti-mouse IgG anti-
body from GE Healthcare at 1:1,000 and 1:2,000 dilutions, respectively.
HIF1a and HIF2a western blots were developed using supersignal west femto
maximum sensitivity substrate (Thermoscientific). All other western blots
were developed using supersignal west pico chemiluminescent substrate
(Thermoscientific).
Quantitative Real-Time PCR
Total RNA was prepared with TRIzol reagent (Invitrogen), cDNA was prepared
with High Capacity cDNA Reverse Transcription kit (Applied Biosystems) with
2 mg total RNA. Quantitative real-time PCR (qRT-PCR) experiments were per-
formed with SYBR Green PCR master mixture (Applied Biosystems). The
primers for DMT1, FPN1, Dcytb, hepcidin, endothelin-1, EPO, HIF1alpha,
HIF2alpha, ALDOA, CCXL12, Bnip3, Retnla, and actin are shown in Table
S1. The results were normalized against actin levels.
Statistical Analyses
Where applicable, data are expressed as the mean ± standard deviation.
Pairwise comparisons between two groups were analyzed using the unpaired
Student’s t test. Analyses of multiple groups were performed using two-way
ANOVA. p values of less than 0.05 were considered statistically significant.
For statistical analysis of mouse survival time, survival curves were plotted
using the Kaplan-Meier method and evaluated by log-rank test using the
XLSTAT software package from Addinsoft.280 Cell Metabolism 17, 271–281, February 5, 2013 ª2013 Elsevier InSUPPLEMENTAL INFORMATION
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